Updated
Original VAYEMA symptom and impact self-check – not a validated scale
Ketamine-related concerns
Answer the symptom statements below to see which experiences and areas of daily life you report as most affected. These are original VAYEMA questions, not a validated diagnostic scale. No clinical severity or probability score is calculated.
Answers are processed only in this page by this assessment. They are not submitted, monitored or automatically saved. No name, email or account is required. Use a private device and clear your answers when finished.
For adults aged 18 and over. This self-check cannot diagnose or rule out a condition. Concerns about a child require an age-appropriate professional assessment.
Thinking about the past four weeks, how well does each statement describe your experience?
Additional context – not included in any questionnaire score
These are original VAYEMA questions, not a diagnostic instrument or a validated severity scale. They summarize the experiences you select and do not predict a diagnosis or future harm. Background condition information; this source does not endorse this self-check.
The assessment should address the concern that brought you here
You may want help with control, be worried about urinary symptoms or have questions about prescribed treatment. Explain that starting point without needing a diagnosis first. An appropriate assessment distinguishes the use pattern from particular medical complications and considers how they interact. The professional should clarify what can be covered and when another clinician or urgent service is required.
The ACMD 2026 review highlights the need for connected addiction, urology, pain and other specialist care. A useful first appointment should identify priorities, not simply place every concern inside a general detoxification package. You can ask what the service actually provides and which arrangements would be needed elsewhere before committing to a program.
Describe the use pattern and identify uncertainty
The clinician may ask about frequency, approximate amounts, route, duration and recent changes, including whether ketamine is prescribed. They also need to understand what you seek from use and what happens afterward. If the product or its contents are uncertain, say so. A single number cannot describe the whole picture, and an estimate should be presented as an estimate rather than adjusted to fit a threshold.
A representative account may be enough to begin. Explain occasions when intended limits changed, urges became difficult or ordinary activities were displaced. The understanding guide explains these patterns. You do not need to reconstruct every event or give detailed personal material in an ordinary website form. A clinical conversation can explore what is relevant in an appropriate private setting.
Urinary symptoms need to be communicated clearly
Tell the receiving clinician about pain passing urine, frequency, urgency, leakage, blood in the urine or waking repeatedly to urinate. Include when symptoms began, how they affect life and any tests already performed. These symptoms may have several causes, and ketamine exposure is important context. Do not assume that an infection has been excluded simply because someone has discussed ketamine, or that a negative infection test rules out other injury.
The BAUS consensus paper addresses assessment of ketamine-related urinary complications. A clinician may recommend examination, urine tests, imaging or specialist referral according to the actual question. The worksheet cannot perform that assessment. Severe pain, inability to pass urine, fever with marked illness or rapid deterioration should be directed to appropriate urgent medical care rather than saved for a later psychological appointment.
Abdominal pain and general health deserve their own review
Abdominal pain, vomiting, poor intake or other physical changes can affect both urgency and the treatment plan. A clinician may need to consider liver, bile-duct, urinary or unrelated medical causes. Symptoms should not be assumed to be harmless cramps because they occur around ketamine use. The assessment needs to connect the history with appropriate examination and investigation, not rely only on a drug-use label.
Bring previous reports when readily available and ask what further tests are intended to clarify. You should know who will explain results and arrange follow-up. If symptoms are serious now, do not delay care while trying to collect a complete file. Missing records can be dealt with by the receiving team; a current medical need should not depend on finishing the website’s preparation questions first.
Discuss pain, craving and attempts to change together
Some people continue using partly because it changes how existing pain feels. Others are mainly concerned about craving, distress or a routine that has become difficult to interrupt. These experiences may overlap. The clinician should understand them without treating pain as an excuse or assuming that psychological motivation is the only issue. A coherent plan needs to address what makes change difficult in practice.
Tell the assessor what happened during earlier reductions or treatment, including symptoms, support and obstacles. Evidence for ketamine-specific withdrawal management remains limited, so a universal online regimen is not appropriate. Do not borrow medicines or use further non-prescribed ketamine to manage pain while waiting. Ask for direct medical advice about current symptoms and how addiction and pain care will be coordinated.
Medical ketamine treatment needs its prescribing context
If ketamine or a related treatment has been prescribed, explain the indication, schedule, monitoring and any recent changes. A prescription alone does not establish addiction, but adverse effects or concerns about craving still deserve review. The original condition being treated matters and should not disappear from the discussion. Contact the responsible prescriber rather than independently change treatment to test a theory.
Oxford Health’s patient information encourages reporting relevant symptoms during medical treatment. That is different from assuming medical use and uncontrolled exposure have identical circumstances. Ask how benefit and risk are being reviewed and what alternatives exist if problems arise. This assessment page is not an offer of ketamine treatment, an eligibility test for it or a substitute for the prescribing clinician’s evaluation.
Mental health and other substances may change the priorities
The professional may ask about depression, anxiety, trauma, dissociation, unusual perceptions, sleep and current safety. Alcohol, sedatives, opioids or other substances can affect symptoms and treatment. Give an accurate account, including medicines from other prescribers. If memory is incomplete or the product is uncertain, explain that. The assessment should consider the combined picture rather than require you to decide which concern is primary before seeking care.
New severe confusion, reduced consciousness, abnormal breathing or inability to remain safe needs urgent help. Do not assume an altered state will resolve safely because it has been called dissociation. For planned care, the clinician can explore symptoms over time and whether separate mental health treatment is needed. Neither an online score nor a brief description can determine the cause of every unusual experience or establish a safe treatment setting.
Understand what screening and investigations cannot decide alone
A screening questionnaire can collect selected information, and tests may address specific exposure or medical questions. Neither independently diagnoses the whole use disorder or predicts the extent of urinary damage. A normal result from one investigation does not answer every health concern. Ask how each test relates to your symptoms and how its findings will change the plan.
The preparation prompts here are not a validated ketamine scale, a dependence score or a clinical organ assessment. There are no probability estimates or pass marks. The NHS treatment overview describes a broader professional conversation about health and circumstances. Repeated self-testing should not replace that discussion or become a reason to wait while a physical symptom is worsening.
Ask for a recommendation that connects the different services
A useful outcome explains immediate medical needs, the proposed addiction treatment, relevant specialist referrals and who coordinates the work. Ask about the first appointments, review points and costs. Physical care should not be deferred until a person has completed psychotherapy, and psychological support should not be assumed unnecessary once one medical symptom is treated. The responsibilities need to fit together.
The ketamine treatment guide explains this approach. The NHS multidisciplinary-care example illustrates why combined expertise can matter. A recommendation may involve another provider or setting. That should be explained honestly rather than implying that a general outpatient clinic delivers every urological, pain or hospital intervention itself.
Keep notes private and the next step manageable
Use only the prompts that help. Avoid names and unnecessary details about other people, leave fields blank and stop when needed. Nothing entered here is sent to VAYEMA, monitored or added to a clinical record. You may review or deliberately download your notes; the resulting file remains on your device and should be kept privately. Clear the page when finished, especially on shared equipment.
You can attend without a worksheet. VAYEMA’s assessment pathway can clarify suitable planned support, with care coordination or family guidance where appropriate. Routine inquiries are not emergency channels. A current serious symptom should be addressed through direct medical care rather than waiting for a booking response or assuming that an entry in these notes will be reviewed.
Frequently asked questions about ketamine assessment
Does this worksheet diagnose ketamine addiction?
No. It offers original, optional preparation notes without a score. A professional assessment considers use, control, consequences, health and other explanations. The worksheet cannot confirm or exclude a disorder, predict withdrawal or determine which treatment setting is safe. You do not need to complete it before seeking help.
Can a self-test tell me whether my bladder is damaged?
No. Urinary symptoms need medical assessment and may require investigations or specialist advice. An online questionnaire cannot examine the bladder or kidneys. Share the ketamine history with the receiving clinician and do not use a low score or a negative infection test as proof that all urinary problems have been excluded.
What should I say if ketamine temporarily reduces my pain?
Tell the clinician honestly. Pain and dependence may be connected and need coordinated treatment. Temporary relief does not establish that ongoing non-prescribed use is safe or that the underlying problem is improving. Ask how pain care and support to stop harmful exposure will be arranged together.
Will prescribed treatment automatically be classified as misuse?
It should not be. The clinician needs the indication, treatment arrangements, benefit, adverse effects and pattern of use. Raise concerns with the responsible prescriber rather than alter treatment independently. A careful assessment distinguishes legitimate treatment from a problematic pattern without ignoring symptoms that require medical review.
Do I need to be abstinent before receiving care for urinary symptoms?
Do not delay seeking medical care while trying to meet an assumed entry requirement. Explain current use and symptoms accurately so clinicians can assess and advise. Stopping harmful exposure is important, but addiction support and medical treatment may need to proceed together. Serious symptoms require prompt attention.
Will typing a serious symptom here contact a clinician?
No. The worksheet is not transmitted or monitored and cannot trigger an alert. Use direct medical contact for current symptoms and emergency services for acute deterioration. A downloaded summary is only a private file you choose to keep, not an appointment request, clinical record or safety assessment.
Resources and references
[1] ACMD 2026: Ketamine use and harms review
[2] BAUS consensus on ketamine-related urinary complications
[3] Oxford Health: Reporting concerns during medical ketamine treatment